glp 1 week 1 Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLpeeeee-1 Day! Leveling up. 💉

Oral tablets = daily rhythm, no needles Injectables = once-weekly convenience and higher absorption Switching is always an option with support at every step Sarah considered starting with oral, but with the right provider support, she transitioned to injectable when her body felt ready

Knowing when to reduce dose or discontinue Not every side effect requires discontinuation, but some warrant reducing dose or stopping use

Conclusion AOMs have the potential to significantly improve population mortality and disease incidence rates

She graduates with a medical degree from National University of Singapore and holds two post graduate diplomas in Family Medicine and Dermatology (Distinction)

Khan serves on an advisory board for Bayer and Novartis